Anchiano Therapeutics IPO prices at $11.50 to raise $30.5 mln

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Anchiano Therapeutics IPO prices below assumed price

Israel-based Anchiano Therapeutics Ltd. said Tuesday said the initial public offering of American Depositary Shares had priced at $11.50 each. With the biotechnology company is offering 2,652,174 ADS to raise $30.5 million, and could raise up to $35.1 million if options granted to underwriters are exercised. The company had previously said it assumed an initial public offering price of $14.55 per ADS. The stock is expected to begin trading Tuesday on the Nasdaq Capital Market under the ticker symbol “ANCN.” The company’s lead underwriters are Oppenheimer and Ladenburg Thalmann. The company is going public at a time that iShares Nasdaq Biotechnology ETF has gained 3.7% over the past three months through Monday and the Renaissance IPO ETF has rallied 7.8%, while the S&P 500 has slipped 0.6%.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply